Samsung’s subsidiary company, Samsung Biologics has seen an increase in its stock price as it recently secured a major contract manufacturing deal of 73 million USD.     Which was evidently seen when SK securities adjusted Samsung BioLogics’ stock price from 340 USD to 400… read more

Biologics: Drugs of the future Consumers are increasingly turning to biological drugs because of its almost pinpoint accuracy in treating specific diseases, making it possible for patients to enjoy safe and effective treatments… read more

The biologics manufacturing industry has undergone several changes over the past few years starting from the development of better expression systems to modular and flexible manufacturing facilities including the emergence and use of… read more